Pharmaceuticals
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma
SYDNEY, April 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for67Cu-SARTATE™, a therapy for the clinica...
2020-04-21 21:13
1214
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
STUART, Florida, April 21, 2020 /PRNewswire/ -- Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed t...
2020-04-21 21:00
2818
Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity
- New, €100 million facility will more than double existing production capacity - Supports large-scale commercial manufacturing of viral and gene therapy products DARMSTADT, Germany, April 21, 2020 /PRNewswire/ -- Merck, a leading science and technology company, today announced a secondCarlsbad,...
2020-04-21 20:00
3053
Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder
* First anti-FcRn PoC study for the treatment of NMOSD * Anti-FcRn antibody with potential to become a portfolio-in-a-product CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, April 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM) today announced first patient dosing in a Phase1b/2a st...
2020-04-21 17:00
3298
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001
SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou) Co., Lim...
2020-04-20 23:00
1131
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today thatthe United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) applic...
2020-04-20 14:41
3387
Fosun Pharma Receives FDA Emergency Use Authorization (EUA) For Its COVID-19 RT-PCR Detection Kit
SHANGHAI, April 19, 2020 According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK)has received emergency use authorization (EUA) from FDA for its COVID-19 RT-PCR detection kit. The t...
2020-04-19 20:00
4981
GC Pharma lights up to celebrate 'World Hemophilia Day'
YONGIN, South Korea, April 17, 2020 /PRNewswire/ -- GC Pharma (formerly known
as Green Cross Corporation), a South Korean biopharmaceutical company,
participate in campaign to celebrate World Hemophilia Day.
2020-04-17 21:00
2751
Fondazione Internazionale Menarini Creates a New Covid-19 "Virtual" Library for Doctors and Nurses: It Takes Only a Click to get the Studies Chosen by Nobel Ignarro
FLORENCE, Italy, April 17, 2020 /PRNewswire/ -- Created by the Menarini International Foundation, the collection of the most distinguished and influential scientific publications on Covid-19, selected and constantly updated under the guidance of the Nobel Prize for Medicine Louis J. Ignarro, mem...
2020-04-17 03:32
3513
Kaneka Agrees to Supply Active Pharmaceutical Ingredients for Avigan® Tablet
TOKYO, April 16, 2020 /PRNewswire/ -- Kaneka Corporation (President: Minoru Tanaka) has reached an agreement with FUJIFILM Corporation (President: Kenji Sukeno) to supply drug substances for anti-influenza drug, Avigan® Tablet (generic name: favipiravir), for the novel coronavirus disease (referr...
2020-04-16 23:33
3456
Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19
BEIJING, April 16, 2020 /PRNewswire/ -- A news report by Science and Technology Daily: Is there any specific drug to fight against COVID-19? When can we get access to the specific drug? These two questions are hard to answer for now. Developing the specific drug is quite tough. It is not practic...
2020-04-16 23:05
2414
Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble's Novel Biomarker Discovery Engine
MADISON, Wisconsin and MALMÖ, Sweden, April 16, 2020 /PRNewswire/ -- Nimble Therapeutics and Svar Life Science today announced a collaboration to discover, develop, and commercialize diagnostic tests based on Nimble's powerful and broadly applicable biomarker discovery engine and Svar's strongin ...
2020-04-16 23:00
1699
IVI, INOVIO, and KNIH to Partner with CEPI in Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine in South Korea
PLYMOUTH MEETING, Pennsylvania and SEOUL, South Korea, April 16, 2020 /PRNewswire/ -- The International Vaccine Institute (IVI) announced today that the Coalition for Epidemic Preparedness Innovations (CEPI) has granted$6.9 million funding to INOVIO (NASDAQ:INO) to work with IVI and the Korea Nat...
2020-04-16 18:00
3274
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
ADELAIDE, Australia and LIEGE, Belgium, April 16, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA), seeking...
2020-04-16 12:30
6010
Three Chinese Vaccines against COVID-19 are on the Way
BEIJING, April 16, 2020 /PRNewswire/ -- According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) ofChina, making them the firs...
2020-04-16 11:03
2377
Australia to test COVID-19 vaccine
MELBOURNE, Australia, April 15, 2020 /PRNewswire/ -- The first COVID-19 vaccine to be tested outside of theUSA, and only the third vaccine clinical trial in the world, will be conducted byAustralia's largest Phase 1 clinical trials specialist Nucleus Network. As part of the urgent global race to...
2020-04-15 11:15
1543
Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19
SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Li...
2020-04-15 05:55
7790
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma
SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ -- Antengene announced today that it has dosed the first patient inTaiwan, China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and...
2020-04-14 21:15
1520
Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen"
SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic ofChina has purchased 700,000 boxes of Lianhua Qingwen and distribute them to eachChinese embassy. The health packages ...
2020-04-13 22:25
2687
Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic
SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...
2020-04-13 21:55
2017
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 334 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 307 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 304 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 302 media titles]
2025-01-21 16:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 288 media titles]
2025-01-20 21:09
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
9917
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
8954
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
8916
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
8753